Otsuka Pharmaceutical Co Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Otsuka Pharmaceutical Co Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C0178
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Otsuka Pharmaceutical Co Ltd (OPC), a subsidiary of Otsuka Holdings Co Ltd is a provider of healthcare products. The company offers products which include pocari sweat, pocari sweat ion water, oronamin c, calorie mate, nature made, jerubure, jarinea, five mini, amino-value, enerugen, jog mate protein jelly, metro mint, the calcium, oronine and new sararin, among others. Its pharmaceutical products are used in the areas of central nervous system, cardiovascular, circulatory disease, infectious diseases, kidney, digestive disease, ophthalmology and dermatology. The company operates in the US, Japan, Belgium, Australia, the UK, Denmark, and others. OPC is headquartered in Tokyo, Japan.

Otsuka Pharmaceutical Co Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Otsuka Pharmaceutical Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deal Details 11
Venture Financing 11
Megakaryon Raises USD9.7 Million in Series C Financing 11
Science 37 Raises USD35 Million in Series C Financing 13
Proteus Digital Health Raises US$63 Million In Series F Financing Round 14
Partnerships 15
Science 37 Enters into Agreement with Otsuka Pharma 15
C2N Diagnostics Enters Into Research Agreement With Cambridge Isotope Labs For Biomarkers 16
NuView Life Sciences Enters into Licensing Agreement with Otsuka Pharma for VPAC1 Biomarker 17
Proteus Biomedical Enters Into Licensing Agreement With Otsuka Pharma 18
Acquisition 19
Egypt Otsuka Pharmaceutical to Acquire 80% Stake in Ateco Pharma 19
Otsuka Pharmaceutical Co Ltd – Key Competitors 20
Otsuka Pharmaceutical Co Ltd – Key Employees 21
Otsuka Pharmaceutical Co Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 28
Recent Developments 29
Legal and Regulatory 29
Dec 13, 2017: Otsuka Pharmaceutical Unveils It’s Completely New Website 29
Other Significant Developments 30
Feb 28, 2018: Otsuka Encourages Start-Ups to Spark the Next Generation of Innovation and Collaboration in Mental Health Care 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Key Facts 2
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Otsuka Pharmaceutical Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Otsuka Pharmaceutical Co Ltd, Deals By Market, 2012 to YTD 2018 8
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Megakaryon Raises USD9.7 Million in Series C Financing 11
Science 37 Raises USD35 Million in Series C Financing 13
Proteus Digital Health Raises US$63 Million In Series F Financing Round 14
Science 37 Enters into Agreement with Otsuka Pharma 15
C2N Diagnostics Enters Into Research Agreement With Cambridge Isotope Labs For Biomarkers 16
NuView Life Sciences Enters into Licensing Agreement with Otsuka Pharma for VPAC1 Biomarker 17
Proteus Biomedical Enters Into Licensing Agreement With Otsuka Pharma 18
Egypt Otsuka Pharmaceutical to Acquire 80% Stake in Ateco Pharma 19
Otsuka Pharmaceutical Co Ltd, Key Competitors 20
Otsuka Pharmaceutical Co Ltd, Key Employees 21
Otsuka Pharmaceutical Co Ltd, Other Locations 22
Otsuka Pharmaceutical Co Ltd, Subsidiaries 22
Otsuka Pharmaceutical Co Ltd, Joint Venture 28

List of Figures
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Otsuka Pharmaceutical Co Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fidelity Life Assurance of Zimbabwe Ltd:企業の戦略・SWOT・財務情報
    Fidelity Life Assurance of Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report Summary Fidelity Life Assurance of Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Freestone Resources Inc (FSNR):企業の財務・戦略的SWOT分析
    Summary Freestone Resources Inc (Freestone Resources) is an oilfield technology company that offers unconventional and conventional oil recovery solutions. The company offers petrozene solvent. Its petrozene solvent offers solutions in operations of tanker sludge, sediment and water, tar residue and …
  • The Medicines Company (MDCO):製薬・医療:M&Aディール及び事業提携情報
    Summary The Medicines Company (TMC) is a biopharmaceutical company, which provides medical solutions for improving health conditions in patients under critical care. The company’s product portfolio comprises marketed products a peptide compound that inhibits an intravenous direct thrombin and needle …
  • Response Biomedical Corp:企業の戦略的SWOT分析
    Response Biomedical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Alcoa Inc:戦略・SWOT・企業財務分析
    Alcoa Inc - Strategy, SWOT and Corporate Finance Report Summary Alcoa Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Institute of Cancer Research-製薬・医療分野:企業M&A・提携分析
    Summary Institute of Cancer Research (ICR), a subsidiary of University of London is a research institute that offers cancer research and education programs. The institute conducts research and develops new therapies for the treatment of cancer including breast and lung cancer. It offers various post …
  • Immunomic Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Immunomic Therapeutics Inc (ITI) is a biotechnology company that specializes in developing vaccines based on the patented lysosomal associated membrane protein or lamp technology. The company's pipeline product portfolio drugs for allergy vaccine therapy and oncology immunotherapy. It develo …
  • New York & Company, Inc.:企業の戦略・SWOT・財務情報
    New York & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary New York & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Futura Medical Plc (FUM):製薬・医療:M&Aディール及び事業提携情報
    Summary Futura Medical Plc (Futura Medical) is a pharmaceutical company that focuses on research and development of novel products for various therapeutic areas, including sexual health and pain relief management. The company focuses on developing pharmaceutical products based on its transdermal dru …
  • Herantis Pharma Plc (HRTIS):企業の財務・戦略的SWOT分析
    Summary Herantis Pharma Plc (Herantis Pharma) operates as a drug development company that offers regenerative medicine for neurodegenerative diseases. The company's pipeline products include CDNF for amyotrophic lateral sclerosis, CDNF for Parkinson’s disease and lymfactin for secondary lymphedema. …
  • Touchstone Exploration Inc (TXP):企業の財務・戦略的SWOT分析
    Summary Touchstone Exploration Inc (Touchstone), formerly Touchstone Resources Ltd is an upstream oil and gas exploration and production company that explores, produces, and develops, oil and gas properties in Trinidad and Tobago. The company holds interests, owns, and operates projects such as WD-4 …
  • Golden Dawn Minerals Inc (GOM):企業の財務・戦略的SWOT分析
    Summary Golden Dawn Minerals Inc (Golden Dawn) is a mining and mineral exploration and development company. it offers acquisition, exploration, operations, management, production, and development of gold, uranium, silver, iron, lead, zinc, base metals, precious metals, and mineral resource deposit p …
  • Boralex Inc:企業の発電所・SWOT分析2018
    Boralex Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • Alberici Corp:企業の戦略的SWOT分析
    Alberici Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Royal KPN N.V.:企業のM&A・事業提携・投資動向
    Royal KPN N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Royal KPN N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Delta Air Lines, Inc.:企業のM&A・事業提携・投資動向
    Delta Air Lines, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Delta Air Lines, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Hetero Drugs Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Hetero Drugs Ltd (Hetero) is a manufacturer of active pharmaceutical ingredients, intermediate chemicals and finished dosages. The company specializes in process chemistry, API manufacturing, formulation development, manufacturing and commercialization of bio-generics, and also offers custom …
  • The New York Times Company (NYT):企業の財務・戦略的SWOT分析
    The New York Times Company (NYT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Purepoint Uranium Group Inc (PTU)
    Purepoint Uranium Group Inc (PTU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Putzmeister Holding GmbH:企業の戦略・SWOT・財務情報
    Putzmeister Holding GmbH - Strategy, SWOT and Corporate Finance Report Summary Putzmeister Holding GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆